Atlas Venture Life Science Advisors »

Dianthus Therapeutics shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.6M 187k 30.00
2023-12-31 $2.5M 237k 10.40
2023-09-30 $3.2M 237k 13.67

More positions owned by Atlas Venture Life Science Advisors

Dyne Therapeutics Common Stock (DYN)
Kymera Therapeutics Common Stock (KYMR)
Disc Medicine Common Stock (IRON)
Day One Biopharmaceuticals Common Stock (DAWN)
Third Harmonic Bio Common Stock (THRD)
Korro Bio Common Stock (KRRO)
Aerovate Therapeutics Common Stock (AVTE)
Q32 Bio Common Stock
Generation Bio Common Stock (GBIO)
Vigil Neuroscience Common Stock (VIGL)
Replimune Group Common Stock (REPL)
Ikena Oncology Common Stock (IKNA)
AvroBio Common Stock (AVRO)
Dianthus Therapeutics Common Stock (DNTH)
Xilio Therapeutics Common Stock (XLO)

View all positions for Atlas Venture Life Science Advisors

Top funds holding Dianthus Therapeutics

Fairmount Funds Management
5AM Venture Management
Avidity Partners Management
VR Adviser
Octagon Capital Advisors
Vanguard Group
Tang Capital Management
Nantahala Capital Management
Alphabet
Susquehanna International
Atlas Venture Life Science Advisors
BlackRock
Fred Alger Management
Pnc Financial Services
Millennium Management

View all funds holding Dianthus Therapeutics